Northern Cancer Alliance Colorectal Symptoms Assessment Pathway

Slides:



Advertisements
Similar presentations
Irritable bowel syndrome in adults
Advertisements

One-stop dyspepsia clinic
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Upper and Lower GI Investigation of Elderly Patients who are Iron Deficient American Journal of Medicine July 1999.
Upper GI 2WW referrals & open access endoscopy Dr Amanda J Hughes.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Iron deficiency anaemia Christian Selinger Consultant Gastroenterologist.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
NICE guidelines: Management of dyspepsia in adults in primary care
Direct Access Flexible Sigmoidoscopy
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
The Use of a Faecal Calprotectin Service in Routine Practice Can Help in Clinical Dilemma and Significantly Reduce Unnecessary Colonoscopy. M. W. Johnson,
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Suspected cancer: recognition and referral NICE guidelines [NG12] Published date: June 2015 also cancer researchuk Dr Jane Wilcock.
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
Diagnosing Iron Deficiency Anaemia in Primary Care Dr Peter Johnson Consultant Haematologist Western General Hospital.
Update The 2 week rule for colorectal cancer Mr Iain Jourdan MS FRCS Director of Surgery Royal Surrey County Hospital.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Quiz.
Fast Track Referrals – Paisley, Rosemary and Time Nick Sharer May 2015.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
PREOPERATIVE ANAEMIA PATHWAY CARDIAC SURGERY CARDIFF AND VALE UHB
FIT Programme (Faecal Immunohistochemical Test)
The Use of Faecal Calprotectin in Primary Care
The capacity challenge:
CRC 101; Part One Julie Banahan, RN, BSN, OCN
An Electronic 2 Week Wait Referral System for Colorectal Cancer
New NICE Guidance There are many combinations of symptoms to consider now but in order to use ICE it is important that you start with the main symptom.
Upper Gastrointestinal Cancers Top ⑩ Tips
CRC 101; Part One Julie Banahan, RN, BSN, OCN
IDA – Lessons from our local service
Colorectal Cancer: Risk Prevention and Diagnosis
Camden Two Week Wait Referrals Feedback
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
The POSITIVE study A large international research effort coordinated by International Breast Cancer Study Group (IBCSG) worldwide ALLIANCE for Clinical.
Presenting with IBS symptoms, baseline assessment.
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Phone triage could remove a large proportion of young non-urgent endoscopy referrals from Irish endoscopy waiting lists B.Christopher, K.Altamimi, C.Egan,
Common cancers and NICE
Session for Action: 2WW forms
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
More than a 2WW referral Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer.
NHS ADULT SCREENING PROGRAMMES
Direct Access Colonoscopy Service (DACS)
What to look out for and why?
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Dr Rob Palmer – CCG Gastro Lead
Breast cancer pathway update – Primary care pathways event
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
Colorectal Cancer Cancer Alliance Work
Worcestershire Colorectal Cancer 2ww Pathway
Currently You send pts for colonoscopy
The Use of Faecal Calprotectin in Primary Care
Diagnosing Iron Deficiency Anaemia in Primary Care
Upper Gastrointestinal Cancer
More than a 2WW referral Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer.
FIT for symptomatic patients
Nursing care of patients operated-on for CRC
Crohn’s Disease Biologic Pathway
Colorectal and General Surgical Topics Relevant to GPs GP update meeting Addington Practice Tuesday 26th March 2014 Mr Steve Warren.
ED Consultant (Imperial)
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Suspected Gynaecological Cancer Recognition & Referral
Colorectal 2 week wait pathways and “Getting FIT”
NCA Colorectal Symptoms Assessment Pathway for Primary Care
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Guidance for investigating colorectal symptoms in primary care including IDA , Faecal.
Suspected Upper GI cancer 2WW pathway: direct access pilot
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Northern Cancer Alliance Colorectal Symptoms Assessment Pathway 2WW Criteria or High risk people confirmed IDA (Men and non-menstruating women >40y) New or persistent lower GI symptoms or abdominal pain for > 3 weeks Unexplained weight loss Rectal bleeding Non-2WW >50Y 2x Platelets >450 6 weeks apart <50Y Offer FIT consider CT if weight loss sx   Possible IBD/ IBS Unexplained confirmed medium risk IDA or clinical suspicion of colorectal cancer   Offer faecal calprotectin test Repeat after 4 weeks if 100 -250   Katie Elliott NCA Rectal Bleeding alone   2WW Referral Positive Fit Negative Fit <100   100-250   >250   Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Safety netting in primary care Consider advice and guidance or routine referral for persistent or troublesome symptoms   Likely IBS Manage in Primary Care   Routine GI referral  Urgent not 2WW referral 

Notes: FiT is 85-90% sensitive for bowel cancer (at lower end of estimate in anaemic patients) and 80% specific at a cut off of 10µ/gm faeces Confirmed IDA may include: IDA = HB < 130g/ L ( MEN) , 115g/ L ( Women) AND Ferritin < 15 or Ferritin < 50 and low MCV or Ferritin <50 and low transferrin. There may be local differences in definition please consult local labs 2. Pre-menopausal women have low risk of colorectal cancer or GI causes of anaemia and most need no testing at all. Risk increases between age 40 and 50. Menstruating women younger than 40 with anaemia and no rectal bleeding should rarely need GI anaemia pathway. 3. Young people (<50), and blood donors with low ferritin alone and normal Hb are extremely unlikely to have GI cause and may need no testing or just TtG. Older ones may be offered FiT. There is no NICE recommendation on low ferritin with a normal Hb. 4. For the low risk patients with anaemia and negative FiT, watchful waiting should be purposeful - it generally requires treatment with adequate oral iron for at least three months to ensure that Hb comes back into normal range and iron stores are filled. It is suggested that the patient has repeat ferritin and Hb at 3 and 6 months after adequate treatment. Recurrent IDA is often due to inadequate treatment. If anaemia recurs or does not resolve despite adequate treatment, then consider referral to gastroenterology to consider bidirectional endoscopy 5. Patients >50 with rectal bleeding qualify for 2ww referral irrespective of anaemia 6. CT colonography is an acceptable means of ruling out bowel cancer as an alternative to colonoscopy and may be offered as a an option form straight to test triage. 7. Urgent 2ww OPA is preferable to direct access endoscopy if age >80 or major organ dysfunction/frailty or patient wishes 8. Calprotectin should not be used for diagnosis in people >50 – use FiT instead (Calprotectin can be used in monitoring known IBD in older patients) 9. This pathway takes into account all NICE guidance + Commissioning advice and Letter from NHC Cancer team and the York faecal calprotectin pathway